CA1025447A - Process for preparing 3,4-dihydrocarbostyril derivatives - Google Patents

Process for preparing 3,4-dihydrocarbostyril derivatives

Info

Publication number
CA1025447A
CA1025447A CA161,000A CA161000A CA1025447A CA 1025447 A CA1025447 A CA 1025447A CA 161000 A CA161000 A CA 161000A CA 1025447 A CA1025447 A CA 1025447A
Authority
CA
Canada
Prior art keywords
preparing
dihydrocarbostyril derivatives
dihydrocarbostyril
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA161,000A
Other languages
English (en)
French (fr)
Other versions
CA161000S (en
Inventor
Shiro Yoshizaki
Yasumitsu Tamura
Michiaki Tominaga
Hideo Mori
Kazuyuki Nakagawa
Nanami Murakami
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP47092558A external-priority patent/JPS5241268B2/ja
Priority claimed from JP47092560A external-priority patent/JPS5246231B2/ja
Priority claimed from JP9255772A external-priority patent/JPS5324431B2/ja
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Application granted granted Critical
Publication of CA1025447A publication Critical patent/CA1025447A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Quinoline Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA161,000A 1972-04-13 1973-01-11 Process for preparing 3,4-dihydrocarbostyril derivatives Expired CA1025447A (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
JP47037182A JPS48103590A (xx) 1972-04-13 1972-04-13
JP47037181A JPS517672B2 (xx) 1972-04-13 1972-04-13
JP47092558A JPS5241268B2 (xx) 1972-09-14 1972-09-14
JP47092560A JPS5246231B2 (xx) 1972-09-14 1972-09-14
JP9255772A JPS5324431B2 (xx) 1972-09-14 1972-09-14
JP47120953A JPS5229745B2 (xx) 1972-04-13 1972-12-02
JP47125858A JPS5239036B2 (xx) 1972-04-13 1972-12-14
JP47128972A JPS5241269B2 (xx) 1972-04-13 1972-12-21

Publications (1)

Publication Number Publication Date
CA1025447A true CA1025447A (en) 1978-01-31

Family

ID=27572212

Family Applications (1)

Application Number Title Priority Date Filing Date
CA161,000A Expired CA1025447A (en) 1972-04-13 1973-01-11 Process for preparing 3,4-dihydrocarbostyril derivatives

Country Status (17)

Country Link
JP (5) JPS517672B2 (xx)
AR (1) AR209575A1 (xx)
AU (1) AU475964B2 (xx)
BE (1) BE794669A (xx)
CA (1) CA1025447A (xx)
CH (1) CH575929A5 (xx)
DD (2) DD112446A5 (xx)
DE (1) DE2302027C2 (xx)
DK (1) DK141603B (xx)
FI (1) FI53703C (xx)
FR (1) FR2179715B1 (xx)
GB (2) GB1424572A (xx)
HK (1) HK19481A (xx)
NL (1) NL158176B (xx)
NO (1) NO140589C (xx)
SE (1) SE380018B (xx)
YU (1) YU41187B (xx)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ300351B6 (cs) * 2005-05-26 2009-04-29 Zentiva, A. S. Zpusob prípravy 7-hydroxy-3,4-dihydrokarbostyrilu

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5082218A (xx) * 1973-11-10 1975-07-03
US4022784A (en) * 1974-01-31 1977-05-10 Otsuka Pharmaceutical Company Limited 5-[1-Hydroxy-2-(substituted-amino)]alkyl-8-substituted-carbostyril and -3,4-dihydrocarbostyril derivatives
US4137331A (en) 1974-06-19 1979-01-30 Sandoz Ltd. 3-Piperidino-2-hydroxypropoxy substituted-2-indolinones
JPS516971A (en) * 1974-07-08 1976-01-20 Otsuka Pharma Co Ltd Nitoro 3*44 jihidorokarubosuchirirujudotaino seizoho
JPS5129486A (en) * 1974-09-02 1976-03-12 Otsuka Pharma Co Ltd * 33 arukiruamino 22 hidorokishi * purohokishi 3 44 jihidorokarubosuchirirujudotai no seizoho
JPS5148674A (en) * 1974-10-17 1976-04-26 Otsuka Pharma Co Ltd 3 44 jihidorokarubosuchirirujudotaino seizoho
JPS5152180A (ja) * 1974-10-31 1976-05-08 Otsuka Pharma Co Ltd Karubosuchirirujudotaino seizoho
JPS5152179A (ja) * 1974-10-31 1976-05-08 Otsuka Pharma Co Ltd Karubosuchirirujudotaino seizoho
JPS5152178A (ja) * 1974-10-31 1976-05-08 Otsuka Pharma Co Ltd Karubosuchirirujudotaino seizoho
FI58329C (fi) * 1974-11-08 1981-01-12 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av i 8-staellning substituerade 5-(3'-alkylamino-2'-hydroxi)propoxi-3,4-dihydrokarbostyrilderivat
US4081447A (en) * 1975-04-09 1978-03-28 Abbott Laboratories 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
CH619453A5 (xx) * 1976-03-17 1980-09-30 Otsuka Pharma Co Ltd
DE2719562C2 (de) * 1976-05-08 1986-05-07 Otsuka Pharmaceutical Co. Ltd., Tokio/Tokyo 3, 4-Dihydrocarbostyrilderivate, Verfahren zu deren Herstellung und Arzneimittel, welche diese enthalten
US4146630A (en) * 1976-11-12 1979-03-27 Boehringer Mannheim Gmbh Blood pressure lowering and adrenergic β-receptor inhibiting 3-(4-phenoxymethylpiperidino)-propyl-phenyl ethers
JPS54130587A (en) * 1978-03-30 1979-10-09 Otsuka Pharmaceut Co Ltd Carbostyryl derivative
DE2960178D1 (en) * 1978-06-06 1981-04-09 Hoechst Ag New substituted phenylpiperazine derivatives, pharmaceutical compositions containing them and process for their preparation
DE2827566A1 (de) * 1978-06-23 1980-01-10 Boehringer Mannheim Gmbh 1,2-dihydro-chinolin-2-on-derivate und verfahren zu ihrer herstellung
AU518814B2 (en) * 1979-01-30 1981-10-22 Otsuka Pharamaceutical Co. Glaucoma treatment
DE3034237A1 (de) * 1979-09-18 1981-04-16 Otsuka Pharmaceutical Co. Ltd., Tokyo Carbostyrilderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende, antihistaminisch wirkende mittel
JPS56122356A (en) * 1980-02-29 1981-09-25 Otsuka Pharmaceut Co Ltd Carbostyril derivative
JPS58103343A (ja) * 1981-12-15 1983-06-20 Ota Seiyaku Kk プロパノ−ルアミン化合物の製造法
JPS597186A (ja) * 1982-07-02 1984-01-14 Ota Seiyaku Kk １，３，２−ジオキサチオラン２−オキシド誘導体
JPS63193086U (xx) * 1987-05-30 1988-12-13
DE3808136A1 (de) * 1988-03-11 1989-09-21 Thomae Gmbh Dr K Arzneimittel, enthaltend chinolin-2,5-dione, neue chinolin-2,5-dione und verfahren zu ihrer herstellung
DK391189A (da) * 1988-08-10 1990-02-11 Otsuka Pharma Co Ltd Carbostyrilderivater
US5266577A (en) * 1988-08-10 1993-11-30 Otsuka Pharmaceutical Company Ltd. Method of treating congestive heart failure using carbostyril derivatives
WO1993004042A1 (fr) * 1991-08-23 1993-03-04 Otsuka Pharmaceutical Co., Ltd. Derive de carbostyrile et antiagregant plaquettaire
ES2048108B1 (es) * 1992-07-17 1994-10-01 Lusochimica Spa Procedimiento para la preparacion de 5-(3-terc-butilamino-2-hidroxipropoxi)-3,4-dihidrocarboestirilo.
IT1264816B1 (it) * 1993-07-28 1996-10-10 Pergam Srl Procedimento per la preparazione di derivati del procedimento per la preparazione di derivati del 3,4-diidrocarbostirile 3,4-diidrocarbostirile

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1058822A (en) * 1963-07-30 1967-02-15 Ici Ltd 3-amino-2-hydroxypropoxy heterocyclic derivatives
CH523899A (de) * 1968-07-05 1972-06-15 Cassella Farbwerke Mainkur Ag Verfahren zur Herstellung von Derivaten des 2-Oxo-1,2-dihydro-chinolins

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ300351B6 (cs) * 2005-05-26 2009-04-29 Zentiva, A. S. Zpusob prípravy 7-hydroxy-3,4-dihydrokarbostyrilu

Also Published As

Publication number Publication date
FR2179715B1 (xx) 1976-12-03
AU475964B2 (en) 1976-09-09
BE794669A (fr) 1973-05-16
GB1424571A (en) 1976-02-11
JPS4976878A (xx) 1974-07-24
JPS48103589A (xx) 1973-12-25
SE380018B (xx) 1975-10-27
GB1424572A (en) 1976-02-11
DE2302027A1 (de) 1973-12-06
JPS48103590A (xx) 1973-12-25
JPS5241269B2 (xx) 1977-10-17
JPS517672B2 (xx) 1976-03-10
FR2179715A1 (xx) 1973-11-23
NL7302353A (xx) 1973-10-16
YU41187B (en) 1986-12-31
DD108293A5 (xx) 1974-09-12
JPS5229745B2 (xx) 1977-08-03
JPS4982673A (xx) 1974-08-08
NO140589B (no) 1979-06-25
HK19481A (en) 1981-05-22
AU5438673A (en) 1974-10-17
NL158176B (nl) 1978-10-16
DK141603C (xx) 1980-10-06
JPS4981373A (xx) 1974-08-06
DE2302027C2 (de) 1983-03-17
YU254979A (en) 1982-10-31
FI53703B (xx) 1978-03-31
JPS5239036B2 (xx) 1977-10-03
AR209575A1 (es) 1977-05-13
DD112446A5 (xx) 1975-04-12
DK141603B (da) 1980-05-05
FI53703C (fi) 1978-07-10
NO140589C (no) 1979-10-03
CH575929A5 (xx) 1976-05-31

Similar Documents

Publication Publication Date Title
AU475964B2 (en) Process for preparing 3,4-dihydrocarbostyril derivatives
CA1005061A (en) Process for the preparation of 3,5,6-tricarboxy-and 2,3,5,6-tetracarboxy-1,4-dihydropyridine derivatives
CA1013746A (en) Process for preparing triazolinone derivatives
HU173507B (hu) Sposob poluchenija proizvodnykh 11,15-bis-tetragidro-piraniloksi-omega-tetrano-16-fenoksi-prostaglandina
YU34884B (en) Process for preparing 1,2,3-tiadiazole derivatives
CA1022555A (en) Carbostyril derivatives and process for preparing the same
CA1021097A (en) Process for preparing poly-ion-complexes
CA963469A (en) 3-substituted-as-triazino (5,6,-c) quinoline derivatives and a process for the preparation thereof
CA1030151A (en) Process for producing 9,10-seco-oestrane derivatives
CA1016545A (en) Phenylisoxazole derivatives and process for preparing the same
YU35588B (en) Process for preparing novel oxo-3-dihydro-2,3-benzoxazine-1,4 derivatives
CA1000704A (en) 1,2,3-triazole derivatives and process for preparing them
CA1025453A (en) Process for preparing 3,4-dihydrocarbostyril derivatives
CA948216A (en) Process for preparing 2,4,4,4-tetrachlorobutanol
ZA7377B (en) Process for preparing 3,4-dihydrocarbostyril derivatives
CA978188A (en) As-triazino(5,6-c)quinoline derivatives and a process for the preparation thereof
AU467691B2 (en) Process for preparing cedrenal
CA1033749A (en) Process for producing 9,10-seco-oestrane derivatives
CA902611A (en) Process for preparing 1,4-benzodiazepin-2-one derivatives
CA969942A (en) Process for preparing 1,4-benzodiazepine derivatives
CA996551A (en) Process for preparing 1-alkylpyrrolidine derivatives
CA990725A (en) Process for preparing 1,2,3,4-tetrahydroisoquinolines
CA911997A (en) 2.alpha.,3.alpha.-EPITHIOANDROSTANE DERIVATIVES AND PROCESS FOR PREPARING THEM
CA857325A (en) Process for preparing 1,3-propanediol derivatives
CA813908A (en) Process for preparing 6-methyl- and 1,6-dimethyl-ergoline i derivatives